- Home
- AVPT vs QURE Comparison
AVPT vs QURE Comparison
Compare AVPT & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVPT
- QURE
- Stock Information
- Founded
- AVPT 2001
- QURE 1998
- Country
- AVPT United States
- QURE Netherlands
- Employees
- AVPT N/A
- QURE N/A
- Industry
- AVPT Computer Software: Prepackaged Software
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- AVPT Technology
- QURE Health Care
- Exchange
- AVPT Nasdaq
- QURE Nasdaq
- Market Cap
- AVPT 3.8B
- QURE 4.3B
- IPO Year
- AVPT N/A
- QURE 2007
- Fundamental
- Price
- AVPT $11.99
- QURE $27.79
- Analyst Decision
- AVPT Buy
- QURE Strong Buy
- Analyst Count
- AVPT 8
- QURE 13
- Target Price
- AVPT $18.38
- QURE $64.67
- AVG Volume (30 Days)
- AVPT 1.2M
- QURE 4.2M
- Earning Date
- AVPT 11-06-2025
- QURE 11-10-2025
- Dividend Yield
- AVPT N/A
- QURE N/A
- EPS Growth
- AVPT N/A
- QURE N/A
- EPS
- AVPT 0.01
- QURE N/A
- Revenue
- AVPT $393,993,000.00
- QURE $14,337,000.00
- Revenue This Year
- AVPT $26.20
- QURE N/A
- Revenue Next Year
- AVPT $18.17
- QURE $229.18
- P/E Ratio
- AVPT $1,537.29
- QURE N/A
- Revenue Growth
- AVPT 24.71
- QURE N/A
- 52 Week Low
- AVPT $11.50
- QURE $5.50
- 52 Week High
- AVPT $20.25
- QURE $71.50
- Technical
- Relative Strength Index (RSI)
- AVPT 24.92
- QURE 31.14
- Support Level
- AVPT $13.72
- QURE $25.52
- Resistance Level
- AVPT $14.60
- QURE $30.19
- Average True Range (ATR)
- AVPT 0.53
- QURE 4.20
- MACD
- AVPT -0.14
- QURE -5.79
- Stochastic Oscillator
- AVPT 13.97
- QURE 10.36
About AVPT AvePoint Inc.
AvePoint Inc provides customizable solutions to optimize SaaS operations, enable secure collaboration, and accelerate digital transformation across technologies and industries. Its Confidence Platform delivers a comprehensive set of cloud-based solutions enabling IT operations, development operations, and cybersecurity professionals to monitor and secure the digital workplace using SaaS tools.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.